Mohammad Zadeh Nadia, Mashinchi Asl Nazli Sadat, Forouharnejad Khatereh, Ghadimi Keyvan, Parsa Sara, Mohammadi Sima, Omidi Ashkan
School of Medicine, Islamic Azad University Tehran Faculty of Medicine Tehran, Iran.
Postdoc Associate, Texas Medical Center Texas, USA.
Int J Physiol Pathophysiol Pharmacol. 2021 Aug 15;13(4):102-109. eCollection 2021.
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19) is chronic, inflammatory. Although the exact mechanisms of COVID-19 have not been yet discovered some drugs are found helpful for its treatment. These drugs which are divided into some lines therapies, have demonstrated to be helpful for COVID-19 patients based on immune basic and its antiviral properties of the disease. Previous studies have been indicated that deterioration of COVID-19 condition is associated with a weaker immune system. Most of these therapies impact on the immune system and immune cells. Beside many beneficial effects of these drugs, some adverse effects (AE) have been reported in many experiments and clinical trials among patients suffering from COVID-19. In this review, we conclude some AEs of vitamin-D, zinc, remdesivir, hydroxychloroquine or chloroquine, azithromycin, dexamethasone, amantadine, aspirin reported in different papers and we continue the rest of the drugs in second part of our review article.
2019冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的一种传染病。2019冠状病毒病(COVID-19)是慢性炎症性疾病。尽管COVID-19的确切机制尚未被发现,但已发现一些药物对其治疗有帮助。这些药物分为几类治疗方法,基于该疾病的免疫基础及其抗病毒特性,已证明对COVID-19患者有帮助。先前的研究表明,COVID-19病情的恶化与免疫系统较弱有关。这些治疗方法大多会影响免疫系统和免疫细胞。除了这些药物的许多有益作用外,在许多针对COVID-19患者的实验和临床试验中还报告了一些不良反应(AE)。在本综述中,我们总结了不同论文中报道的维生素D、锌、瑞德西韦、羟氯喹或氯喹、阿奇霉素、地塞米松、金刚烷胺、阿司匹林的一些不良反应,我们将在综述文章的第二部分继续讨论其余药物。